Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB

Gut

Volumn 63, Issue 12, 2014, Pages 1951-1959

  Sonnweber, Thomas ^a   Nachbaur, David ^a   Schroll, Andrea ^a   Nairz, Manfred ^a   Seifert, Markus ^a   Demetz, Egon ^a   Haschka, David ^a   Mitterstiller, Anna Maria ^a   Kleinsasser, Axel ^a   Burtscher, Martin ^b   Trübsbach, Susanne ^a   Murphy, Anthony T ^c   Wroblewski, Victor ^c   Witcher, Derrick R ^c   Mleczko Sanecka, Katarzyna ^d   Vecchi, Chiara ^e   Muckenthaler, Martina U ^d   Pietrangelo, Antonello ^e   Theurl, Igor ^a   Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894730959     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305317     Document Type: Article

References (50)

1. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011;364:656-65.
2. Harrison DE, Russell ES. The response of W-W v and Sl-Sl d anaemic mice to haemopoietic stimuli. Br J Haematol 1972;22:155-68.
3. Semenza GL. Life with oxygen. Science 2007;318:62-4.
4. Aisen P, Enns C, Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 2001;33:940-59.
5. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-5.
6. Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of Mammalian iron metabolism. Cell 2010;142:24-38.
7. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-19.
8. Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol 2012;54:173-81.
9. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
10. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009;113:5277-86.
11. Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005;2:399-409.
12. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-9.
13. Casanovas G, Mleczko-Sanecka K, Altamura S, et al. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J Mol Med (Berl) 2009;87:471-80.
14. Verga Falzacappa MV, Vujic Spasic M, Kessler R, et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007;109:353-8.
15. Pietrangelo A, Dierssen U, Valli L, et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 2007;132:294-300.
16. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006;108:3204-9.
17. Vecchi C, Montosi G, Zhang K, et al. ER stress controls iron metabolism through induction of hepcidin. Science 2009;325:877-80.
18. Island ML, Fatih N, Leroyer P, et al. GATA-4 transcription factor regulates hepatic hepcidin expression. Biochem J 2011;437:477-82.
19. Camaschella C, Silvestri L. New and old players in the hepcidin pathway. Haematologica 2008;93:1441-4.
20. Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med 2010;62:347-60.
21. Nairz M, Schroll A, Sonnweber T, et al. The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol 2011;12:1691-702.
22. Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol 2008;6:541-52.
23. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007;117:1926-32.
24. Semenza GL, Koury ST, Nejfelt MK, et al. Cell-type-speci fic and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci USA 1991;88:8725-9.
25. Choi SO, Cho YS, Kim HL, et al. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem Biophys Res Commun 2007;356:312-17.
26. Braliou GG, Verga Falzacappa MV, Chachami G, et al. 2-Oxoglutarate-dependent oxygenases control hepcidin gene expression. J Hepatol 2008;48:801-10.
27. Chaston TB, Matak P, Pourvali K, et al. Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling. Am J Physiol Cell Physiol 2011;300:C888-95.
28. Piperno A, Galimberti S, Mariani R, et al. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood 2010;117:2953-9.
29. Talbot NP, Lakhal S, Smith TG, et al. Regulation of hepcidin expression at high altitude. Blood 2011;119:857-60.
30. Goetze O, Schmitt J, Spliethoff K, et al. Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers. Hepatology 2013;58:2153-62.
31. Theurl I, Schroll A, Sonnweber T, et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 2011;118: 4977-84.
32. Ludwiczek S, Theurl I, Muckenthaler MU, et al. Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med 2007;13:448-54.
33. Nairz M, Schroll A, Moschen AR, et al. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappaB-inducible immune pathways. Immunity 2011;34:61-74.
34. Brines M, Cerami A. Erythropoietin and engineered innate repair activators. Methods Mol Biol 2013;982:1-11.
35. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and infl ammation. J Clin Invest 2002;110:1037-44.
36. Garat CV, Crossno JT Jr, Sullivan TM, et al. Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit. J Cardiovasc Pharmacol 2010;55:469-80.
37. Schito L, Rey S, Tafani M, et al. Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci USA 2012;109:E2707-16.
38. Courselaud B, Pigeon C, Inoue Y, et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 2002;277:41163-70.
39. Goodnough JB, Ramos E, Nemeth E, et al. Inhibition of hepcidin transcription by growth factors. Hepatology 2012;56:291-9.
40. Ashby DR, Gale DP, Busbridge M, et al. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 2009;95:505-8.
41. Robach P, Recalcati S, Girelli D, et al. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin. Blood 2009;113:6707-15.
42. Weiss G, Houston T, Kastner S, et al. Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells. Blood 1997;89:680-7.
43. Pak M, Lopez MA, Gabayan V, et al. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006;108:3730-5.
44. Liu Q, Davidoff O, Niss K, et al. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest 2012;122:4635-44.
45. Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007;13:1096-101.
46. Janmaat ML, Heerkens JL, de Bruin AM, et al. Erythropoietin accelerates smooth muscle cell-rich vascular lesion formation in mice through endothelial cell activation involving enhanced PDGF-BB release. Blood 2010;115:1453-60.
47. Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 2004;15:197-204.
48. Theurl I, Schroll A, Nairz M, et al. Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica 2011;96:1761-9.
49. Wallace DF, McDonald CJ, Ostini L, et al. Blunted hepcidin response to inflammation in the absence of Hfe and transferrin receptor 2. Blood 2011;117:2960-6.
50. Pantopoulos K. Function of the hemochromatosis protein HFE: Lessons from animal models. World J Gastroenterol 2008;14:6893-901.